Sphere Bio expands its APAC distributor network, enhancing access to single-cell analysis technologies in key Asian and Pacific markets.

Signals One spans the entire “Design-Make-Test-Decide” R&D lifecycle and empowers researchers to address previously “undruggable” targets.

Thermo Fisher Scientific has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generation, atomic-resolution platform leverages enhanced optics and AI-enabled automation to study molecular structures.

BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer virtual access for worldwide attendees.

Biotech Fluidics introduces QuickStart™, a digital in-line pressure sensor designed for accurate fluid monitoring in lab systems.

LGM Pharma announces a $6M investment to expand its Rosenberg, Texas facility, enhancing its capacity for liquid, semi-solid and suppository drug production. The expansion supports growing prescription drug demand.

BIOVECTRA, part of Agilent Technologies, has been awarded the 2025 Outsourced Pharma CDMO Leadership Award in biologics for its exceptional quality, reliability and technical capability.

Thermo Fisher Scientific introduces the Thermo Scientific™ TSX™ Core Series ULT freezers, designed to provide reliable performance and robust durability in a user-friendly solution.

ProBioGen and Marea Therapeutics, Inc., a clinical-stage biotechnology company, announced the successful completion of a sprint project to deliver clinical material.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).